Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma. (Q53507412)
Jump to navigation
Jump to search
scientific article published in November 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma. |
scientific article published in November 2000 |
Statements
Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma. (English)
1 reference
Fish JE
1 reference
Karpel JP
1 reference
Craig TJ
1 reference
Bensch GW
1 reference
Noonan M
1 reference
Webb DR
1 reference
Silverman B
1 reference
Schenkel EJ
1 reference
Rooklin AR
1 reference
Ramsdell JW
1 reference
Nathan R
1 reference
Leflein JG
1 reference
Grossman J
1 reference
Graft DF
1 reference
Gower RG
1 reference
Garay SM
1 reference
Frigas E
1 reference
Degraff AC
1 reference
Bronsky EA
1 reference
Bernstein DI
1 reference
Berger W
1 reference
Shneyer L
1 reference
Nolop KB
1 reference
Harrison JE
1 reference
1 November 2000
1 reference
106
1 reference
5
1 reference
852-860
1 reference
Identifiers
1 reference